These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 88024

  • 1. Isoprinosine in subacute sclerosing panencephalitis.
    Huttenlocher PR, Mattson RH.
    Neurology; 1979 Jun; 29(6):763-71. PubMed ID: 88024
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid IgG changes in subacute sclerosing panencephalitis in the various stages of the disease and during isoprinosine therapy.
    Poloni M, Rocchelli B, Lanzi G, Rosano Burgio F, Besana D.
    Ital J Neurol Sci; 1981 May; 2(2):177-84. PubMed ID: 6174478
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine].
    Filipowicz A, Grudzińska B.
    Neurol Neurochir Pol; 1987 May; 21(4-5):352-6. PubMed ID: 2451185
    [Abstract] [Full Text] [Related]

  • 6. The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE).
    Streletz LJ, Cracco J.
    Ann Neurol; 1977 Feb; 1(2):183-4. PubMed ID: 70187
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lymphocyte subpopulations in blood and cerebrospinal fluid from patients with subacute sclerosing panencephalitis.
    Marrosu MG, Cianchetti C, Tondi M, Ennas MG, Marrosu G, Murru MR, Manconi PE.
    Acta Neurol Scand; 1983 Jan; 67(1):55-63. PubMed ID: 6188314
    [Abstract] [Full Text] [Related]

  • 10. Long-term study of isoprinosine in a case of subacute sclerosing panencephalitis.
    De Reuck JL, Boon PA, Krahel NL.
    Eur Neurol; 1985 Jan; 24(5):294-7. PubMed ID: 2414109
    [Abstract] [Full Text] [Related]

  • 11. Alpha-interferon and isoprinosine in adult-onset subacute sclerosing panencephalitis.
    Gokcil Z, Odabasi Z, Demirkaya S, Eroglu E, Vural O.
    J Neurol Sci; 1999 Jan 01; 162(1):62-4. PubMed ID: 10064170
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of isoprinosine in subacute sclerosing panencephalitis.
    McGrath E, Rosenbloom L.
    Arch Dis Child; 1980 Oct 01; 55(10):829-30. PubMed ID: 6159826
    [No Abstract] [Full Text] [Related]

  • 16. Isoprinosine therapy and SSPE.
    Huttenlocker PR.
    Ann Neurol; 1980 Dec 01; 8(6):642. PubMed ID: 6163393
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis.
    Gascon G, Yamani S, Crowell J, Stigsby B, Nester M, Kanaan I, Jallu A.
    Brain Dev; 1993 Dec 01; 15(5):346-55. PubMed ID: 7506498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.